Brandon Ingram's 2018-19 NBA campaign was cut short due to blood clots in his arm, a scary event for anyone.
Now, the youngster is about to begin a new season with a new team, as he was traded from the Los Angeles Lakers to the New Orleans Pelicans in a deal that sent Anthony Davis to Hollywood back in June.
Obviously, there has been quite a bit of concern surrounding Ingram's health heading into this year, but he says he no longer has to take any more medication for his blood clots and expects to be fully healthy going forward, according to Andrew Lopez of ESPN.
Ingram is coming off a season in which he played just 52 games, as he also missed time due to ankle issues. During the time he was on the floor, he averaged 18.3 points, 5.1 rebounds and 3.0 assists over 33.8 minutes per game while shooting 49.7 percent from the floor, 33.0 percent from 3-point range and 67.5 percent from the free-throw line.
The 22-year-old, who played his collegiate basketball at Duke, was originally selected by the Lakers with the second overall pick of the 2016 NBA Draft.
He appeared in 79 contests during his rookie year, registering 9.4 points, 4.0 boards and 2.1 assists across 28.8 minutes a night while making 40.2 percent of his field goal attempts, 29.4 percent of his long-distance tries and 62.1 percent of his foul shots.
Then, in his second season, injuries started to pop up, as Ingram was limited to just 59 games and recorded 16.1 points, 5.3 rebounds and 3.9 assists through 33.5 minutes per game while connecting on 47.0 percent of his shots, 39.0 percent of his triples and 68.1 percent of his free throws.
Follow Us
Subscribe